MRVL vs SABSW · P/E 100, rev $8.19B vs P/E 0.0
Marvell Technology Group Ltd (MRVL) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
SABSW does not have a complete income-statement cache yet.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the MRVL and SABSW stock pages for the full models.
Not investment advice.